StockTipsArenaBeta

SELL Fortis Healthcare — Rajesh Palviya, Axis Securities

SELLFortis Healthcare
Fortis Healthcare share price target & all analyst calls

byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))12 Aug 2026via CNBC Awaaz.

Entry₹891.9Inferred
Target₹865
Total upside +3.02% (call closed)
Stop loss₹905-1.47% risk
Exit₹90514 Aug 2026, 9:15 am
Stop-loss hit-1.47%
Follow Rajesh Palviya for new calls(27% target hit, 178 closed calls)Get alertsWatch FORTIS for new buy/sell callsGet alertsSee 1 active Swing call on FORTISSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 14 Aug 2026
2 supporting4 neutral3 opposing
Supports the SELL call (2)

Fortis Healthcare Shares Decline Over 2%; Stock Among Top Losers on Nifty Midcap 150

NewsGoogle News·12 Aug · yesterday

(opens in new tab)

1 other SEBI-registered advisor has an active swing SELL call on this stock, issued in the last 14 days

Advisor consensus · same horizon·12 Aug · yesterday

Neutral / worth noting (4)

Fortis Healthcare Q1 Results: Profit Growth Muted As Margins Contract; Revenue Up 17%

NewsNdtv-Profit·6 Aug · 1w ago

(opens in new tab)

Fortis Healthcare announced its Q1 FY27 financial results, reporting consolidated revenues of INR 2,545 Cr and operating EBITDA margin of 22.3%. The company also highlighted growth in its hospital and

NSE · Press Release·6 Aug · 1w ago

(opens in new tab)

Fortis Healthcare Ltd has submitted a press release regarding its financial results for the quarter ended June 30, 2026, as per SEBI regulations. The document contains financial highlights and busines

BSE · Company Update·6 Aug · 1w ago

(opens in new tab)

Fortis Healthcare Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·6 Aug · 1w ago

(opens in new tab)
Weighs against the SELL call (3)

Fortis Healthcare Q1 Review: Analysts Bullish Despite Short-Term Margin Pressure — Should You Buy?

NewsNdtv-Profit·10 Aug · 4d ago

(opens in new tab)

Fortis Healthcare Q1 profit rises 2%; hospital revenue grows 19% on higher occupied beds

NewsCnbc-Tv18·6 Aug · 1w ago

(opens in new tab)

Fortis Healthcare Q1 Results: Profit rises 2.3% to Rs 273 crore

NewsEt-Markets·6 Aug · 1w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Fortis Healthcare

All analyst calls on Fortis Healthcare

More from Rajesh Palviya, Axis Securities

Every call and its outcome